Difference between revisions of "HCmeddev"

From wiki
Jump to navigation Jump to search
Line 16: Line 16:
 
*[[Media:Deck Information Session – Feb 2021 V2 EN.pdf|Information session: Regulations Amending the Medical Devices Regulations (February 2021)]]
 
*[[Media:Deck Information Session – Feb 2021 V2 EN.pdf|Information session: Regulations Amending the Medical Devices Regulations (February 2021)]]
 
*[[Media:Deck Post-market regulations – FRN – Jun 2021 V2 EN.pdf|Medical Devices Regulations: Foreign Risk Notification (June 2021)]]
 
*[[Media:Deck Post-market regulations – FRN – Jun 2021 V2 EN.pdf|Medical Devices Regulations: Foreign Risk Notification (June 2021)]]
 +
*[[Media:MedTech_2021_Summary_Reports_GCwiki.pdf|Information session: Summary Report (MedTech 2021)]]
 
*  
 
*  
  

Revision as of 09:59, 11 March 2022

Welcome!

This page was developed to share resources related to the new post-market provisions under the Medical Devices Regulations, published in Canada Gazette, Part II on December 23, 2020.

If you have questions, please contact Health Canada's Medical Devices Directorate at mdd.postmarket-postcommercialisation.dim@hc-sc.gc.ca.

Links to online resources

Four guidance documents are available to support the interpretation of the new or updated post-market provisions in the Medical Devices Regulations that were published in Canada Gazette Part II on December 23, 2020. The "List of regulatory agencies and foreign jurisdictions" sets out the regulatory agencies and foreign jurisdictions for the purposes of section 61.2 of the Regulations.

Presentations

Information sessions have been offered by Health Canada related to the new post-market provisions. Presentation slide decks are available for viewing.

Questions & answers

Questions & answers documents were prepared in response to enquiries received.

Foreign risk notification (FRN)

Summary Report

Forms

Forms are available to support compliance with the new regulations.

Foreign risk notification (FRN)